nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP1A2—chronic obstructive pulmonary disease	0.346	1	CbGaD
Cilostazol—PDE3A—Aminophylline—chronic obstructive pulmonary disease	0.224	0.476	CbGbCtD
Cilostazol—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0321	0.0683	CbGbCtD
Cilostazol—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0321	0.0683	CbGbCtD
Cilostazol—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0252	0.0536	CbGbCtD
Cilostazol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0244	0.0519	CbGbCtD
Cilostazol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0244	0.0519	CbGbCtD
Cilostazol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0218	0.0463	CbGbCtD
Cilostazol—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0205	0.0436	CbGbCtD
Cilostazol—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0138	0.0294	CbGbCtD
Cilostazol—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0135	0.0287	CbGbCtD
Cilostazol—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0132	0.0281	CbGbCtD
Cilostazol—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0118	0.025	CbGbCtD
Cilostazol—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00691	0.0147	CbGbCtD
Cilostazol—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00652	0.0139	CbGbCtD
Cilostazol—Aripiprazole—SLC6A4—chronic obstructive pulmonary disease	0.000862	0.565	CrCbGaD
Cilostazol—Aripiprazole—HTR2A—chronic obstructive pulmonary disease	0.000662	0.435	CrCbGaD
Cilostazol—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00131	CcSEcCtD
Cilostazol—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00129	CcSEcCtD
Cilostazol—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00128	CcSEcCtD
Cilostazol—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00128	CcSEcCtD
Cilostazol—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000192	0.00127	CcSEcCtD
Cilostazol—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00127	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000192	0.00127	CcSEcCtD
Cilostazol—Cough—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00127	CcSEcCtD
Cilostazol—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00127	CcSEcCtD
Cilostazol—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00126	CcSEcCtD
Cilostazol—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00125	CcSEcCtD
Cilostazol—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00125	CcSEcCtD
Cilostazol—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.00124	CcSEcCtD
Cilostazol—Cough—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Cilostazol—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00123	CcSEcCtD
Cilostazol—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00123	CcSEcCtD
Cilostazol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00123	CcSEcCtD
Cilostazol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.00123	CcSEcCtD
Cilostazol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.00123	CcSEcCtD
Cilostazol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00123	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00123	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00123	CcSEcCtD
Cilostazol—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00122	CcSEcCtD
Cilostazol—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00122	CcSEcCtD
Cilostazol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00121	CcSEcCtD
Cilostazol—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00121	CcSEcCtD
Cilostazol—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00121	CcSEcCtD
Cilostazol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000182	0.00121	CcSEcCtD
Cilostazol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00121	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000182	0.0012	CcSEcCtD
Cilostazol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000181	0.0012	CcSEcCtD
Cilostazol—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.0012	CcSEcCtD
Cilostazol—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.0012	CcSEcCtD
Cilostazol—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00018	0.0012	CcSEcCtD
Cilostazol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00119	CcSEcCtD
Cilostazol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00119	CcSEcCtD
Cilostazol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00118	CcSEcCtD
Cilostazol—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00118	CcSEcCtD
Cilostazol—Infection—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00118	CcSEcCtD
Cilostazol—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00118	CcSEcCtD
Cilostazol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00117	CcSEcCtD
Cilostazol—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00117	CcSEcCtD
Cilostazol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00117	CcSEcCtD
Cilostazol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.00117	CcSEcCtD
Cilostazol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00116	CcSEcCtD
Cilostazol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00116	CcSEcCtD
Cilostazol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00116	CcSEcCtD
Cilostazol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.00116	CcSEcCtD
Cilostazol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00116	CcSEcCtD
Cilostazol—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00116	CcSEcCtD
Cilostazol—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00116	CcSEcCtD
Cilostazol—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00115	CcSEcCtD
Cilostazol—Infection—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00115	CcSEcCtD
Cilostazol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00115	CcSEcCtD
Cilostazol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00115	CcSEcCtD
Cilostazol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00114	CcSEcCtD
Cilostazol—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00114	CcSEcCtD
Cilostazol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00113	CcSEcCtD
Cilostazol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00112	CcSEcCtD
Cilostazol—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00111	CcSEcCtD
Cilostazol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00111	CcSEcCtD
Cilostazol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00111	CcSEcCtD
Cilostazol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.0011	CcSEcCtD
Cilostazol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.0011	CcSEcCtD
Cilostazol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.0011	CcSEcCtD
Cilostazol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00109	CcSEcCtD
Cilostazol—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00109	CcSEcCtD
Cilostazol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00109	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00108	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00108	CcSEcCtD
Cilostazol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00107	CcSEcCtD
Cilostazol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00107	CcSEcCtD
Cilostazol—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00107	CcSEcCtD
Cilostazol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.00107	CcSEcCtD
Cilostazol—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00106	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00106	CcSEcCtD
Cilostazol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00106	CcSEcCtD
Cilostazol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00106	CcSEcCtD
Cilostazol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00105	CcSEcCtD
Cilostazol—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00105	CcSEcCtD
Cilostazol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00105	CcSEcCtD
Cilostazol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00104	CcSEcCtD
Cilostazol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00104	CcSEcCtD
Cilostazol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00104	CcSEcCtD
Cilostazol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.00104	CcSEcCtD
Cilostazol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00103	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00102	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00102	CcSEcCtD
Cilostazol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00102	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00102	CcSEcCtD
Cilostazol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00101	CcSEcCtD
Cilostazol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00101	CcSEcCtD
Cilostazol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00101	CcSEcCtD
Cilostazol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00101	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000151	0.001	CcSEcCtD
Cilostazol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000998	CcSEcCtD
Cilostazol—Pain—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000993	CcSEcCtD
Cilostazol—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000993	CcSEcCtD
Cilostazol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.000991	CcSEcCtD
Cilostazol—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000987	CcSEcCtD
Cilostazol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000986	CcSEcCtD
Cilostazol—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000985	CcSEcCtD
Cilostazol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.000983	CcSEcCtD
Cilostazol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.000982	CcSEcCtD
Cilostazol—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000979	CcSEcCtD
Cilostazol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000977	CcSEcCtD
Cilostazol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000977	CcSEcCtD
Cilostazol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.000976	CcSEcCtD
Cilostazol—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000974	CcSEcCtD
Cilostazol—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000973	CcSEcCtD
Cilostazol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.000972	CcSEcCtD
Cilostazol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00097	CcSEcCtD
Cilostazol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00097	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000967	CcSEcCtD
Cilostazol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000958	CcSEcCtD
Cilostazol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00095	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00095	CcSEcCtD
Cilostazol—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000942	CcSEcCtD
Cilostazol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000942	CcSEcCtD
Cilostazol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000938	CcSEcCtD
Cilostazol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000938	CcSEcCtD
Cilostazol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000938	CcSEcCtD
Cilostazol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000938	CcSEcCtD
Cilostazol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.000934	CcSEcCtD
Cilostazol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.000927	CcSEcCtD
Cilostazol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.000926	CcSEcCtD
Cilostazol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.000926	CcSEcCtD
Cilostazol—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000923	CcSEcCtD
Cilostazol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000923	CcSEcCtD
Cilostazol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.000921	CcSEcCtD
Cilostazol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000918	CcSEcCtD
Cilostazol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000918	CcSEcCtD
Cilostazol—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000917	CcSEcCtD
Cilostazol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000916	CcSEcCtD
Cilostazol—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000909	CcSEcCtD
Cilostazol—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000904	CcSEcCtD
Cilostazol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000903	CcSEcCtD
Cilostazol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00089	CcSEcCtD
Cilostazol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000885	CcSEcCtD
Cilostazol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000885	CcSEcCtD
Cilostazol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.000873	CcSEcCtD
Cilostazol—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00087	CcSEcCtD
Cilostazol—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00013	0.00416	CbGpPWpGaD
Cilostazol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000851	CcSEcCtD
Cilostazol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000851	CcSEcCtD
Cilostazol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000839	CcSEcCtD
Cilostazol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000839	CcSEcCtD
Cilostazol—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00406	CbGpPWpGaD
Cilostazol—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00405	CbGpPWpGaD
Cilostazol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000834	CcSEcCtD
Cilostazol—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00404	CbGpPWpGaD
Cilostazol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000822	CcSEcCtD
Cilostazol—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000123	0.00394	CbGpPWpGaD
Cilostazol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000812	CcSEcCtD
Cilostazol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000812	CcSEcCtD
Cilostazol—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.0039	CbGpPWpGaD
Cilostazol—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.0039	CbGpPWpGaD
Cilostazol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000804	CcSEcCtD
Cilostazol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000795	CcSEcCtD
Cilostazol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.00385	CbGpPWpGaD
Cilostazol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000792	CcSEcCtD
Cilostazol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000784	CcSEcCtD
Cilostazol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000784	CcSEcCtD
Cilostazol—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.0038	CbGpPWpGaD
Cilostazol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000768	CcSEcCtD
Cilostazol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000766	CcSEcCtD
Cilostazol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000754	CcSEcCtD
Cilostazol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000754	CcSEcCtD
Cilostazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00365	CbGpPWpGaD
Cilostazol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000748	CcSEcCtD
Cilostazol—Rash—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000748	CcSEcCtD
Cilostazol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000747	CcSEcCtD
Cilostazol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000747	CcSEcCtD
Cilostazol—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000113	0.00362	CbGpPWpGaD
Cilostazol—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00362	CbGpPWpGaD
Cilostazol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000743	CcSEcCtD
Cilostazol—Headache—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000743	CcSEcCtD
Cilostazol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000741	CcSEcCtD
Cilostazol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000739	CcSEcCtD
Cilostazol—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00357	CbGpPWpGaD
Cilostazol—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000111	0.00357	CbGpPWpGaD
Cilostazol—Rash—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000732	CcSEcCtD
Cilostazol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000732	CcSEcCtD
Cilostazol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00354	CbGpPWpGaD
Cilostazol—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.00073	CcSEcCtD
Cilostazol—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00011	0.00353	CbGpPWpGaD
Cilostazol—Headache—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000728	CcSEcCtD
Cilostazol—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000721	CcSEcCtD
Cilostazol—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.0035	CbGpPWpGaD
Cilostazol—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000717	CcSEcCtD
Cilostazol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000712	CcSEcCtD
Cilostazol—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00071	CcSEcCtD
Cilostazol—PDE3A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000107	0.00344	CbGpPWpGaD
Cilostazol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000707	CcSEcCtD
Cilostazol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000706	CcSEcCtD
Cilostazol—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000706	CcSEcCtD
Cilostazol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000705	CcSEcCtD
Cilostazol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000705	CcSEcCtD
Cilostazol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000705	CcSEcCtD
Cilostazol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000702	CcSEcCtD
Cilostazol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000692	CcSEcCtD
Cilostazol—PDE3A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000104	0.00335	CbGpPWpGaD
Cilostazol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00069	CcSEcCtD
Cilostazol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00068	CcSEcCtD
Cilostazol—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00324	CbGpPWpGaD
Cilostazol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000665	CcSEcCtD
Cilostazol—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.99e-05	0.000662	CcSEcCtD
Cilostazol—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.97e-05	0.00066	CcSEcCtD
Cilostazol—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.92e-05	0.000657	CcSEcCtD
Cilostazol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.72e-05	0.00312	CbGpPWpGaD
Cilostazol—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.7e-05	0.000642	CcSEcCtD
Cilostazol—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.55e-05	0.00307	CbGpPWpGaD
Cilostazol—Shock—Prednisolone—chronic obstructive pulmonary disease	9.54e-05	0.000632	CcSEcCtD
Cilostazol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.46e-05	0.000627	CcSEcCtD
Cilostazol—PDE3A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	9.27e-05	0.00298	CbGpPWpGaD
Cilostazol—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.24e-05	0.00297	CbGpPWpGaD
Cilostazol—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.13e-05	0.00293	CbGpPWpGaD
Cilostazol—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.11e-05	0.00293	CbGpPWpGaD
Cilostazol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9e-05	0.000596	CcSEcCtD
Cilostazol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.94e-05	0.00287	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.92e-05	0.00286	CbGpPWpGaD
Cilostazol—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	8.92e-05	0.00286	CbGpPWpGaD
Cilostazol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.77e-05	0.000581	CcSEcCtD
Cilostazol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.71e-05	0.0028	CbGpPWpGaD
Cilostazol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.71e-05	0.000577	CcSEcCtD
Cilostazol—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.6e-05	0.00276	CbGpPWpGaD
Cilostazol—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.39e-05	0.0027	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	8.39e-05	0.0027	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	8.39e-05	0.0027	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	8.32e-05	0.00267	CbGpPWpGaD
Cilostazol—Pain—Prednisolone—chronic obstructive pulmonary disease	8.29e-05	0.000549	CcSEcCtD
Cilostazol—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	8.27e-05	0.00266	CbGpPWpGaD
Cilostazol—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	8.18e-05	0.00263	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.1e-05	0.0026	CbGpPWpGaD
Cilostazol—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.03e-05	0.00258	CbGpPWpGaD
Cilostazol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.01e-05	0.00257	CbGpPWpGaD
Cilostazol—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000531	CcSEcCtD
Cilostazol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.99e-05	0.000529	CcSEcCtD
Cilostazol—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000529	CcSEcCtD
Cilostazol—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.94e-05	0.00255	CbGpPWpGaD
Cilostazol—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.91e-05	0.00254	CbGpPWpGaD
Cilostazol—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	7.85e-05	0.00252	CbGpPWpGaD
Cilostazol—Malaise—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000516	CcSEcCtD
Cilostazol—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000514	CcSEcCtD
Cilostazol—Syncope—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.000513	CcSEcCtD
Cilostazol—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.7e-05	0.00247	CbGpPWpGaD
Cilostazol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.00051	CcSEcCtD
Cilostazol—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.6e-05	0.00244	CbGpPWpGaD
Cilostazol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.000503	CcSEcCtD
Cilostazol—PDE3A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	7.5e-05	0.00241	CbGpPWpGaD
Cilostazol—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.45e-05	0.000494	CcSEcCtD
Cilostazol—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.37e-05	0.00237	CbGpPWpGaD
Cilostazol—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000487	CcSEcCtD
Cilostazol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000487	CcSEcCtD
Cilostazol—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000485	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000484	CcSEcCtD
Cilostazol—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000481	CcSEcCtD
Cilostazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.21e-05	0.00232	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.19e-05	0.00231	CbGpPWpGaD
Cilostazol—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.11e-05	0.00229	CbGpPWpGaD
Cilostazol—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.08e-05	0.00227	CbGpPWpGaD
Cilostazol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.06e-05	0.00227	CbGpPWpGaD
Cilostazol—Oedema—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000467	CcSEcCtD
Cilostazol—Infection—Prednisone—chronic obstructive pulmonary disease	7e-05	0.000464	CcSEcCtD
Cilostazol—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.98e-05	0.00224	CbGpPWpGaD
Cilostazol—Shock—Prednisone—chronic obstructive pulmonary disease	6.93e-05	0.000459	CcSEcCtD
Cilostazol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000458	CcSEcCtD
Cilostazol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.88e-05	0.000456	CcSEcCtD
Cilostazol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.000453	CcSEcCtD
Cilostazol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.79e-05	0.00218	CbGpPWpGaD
Cilostazol—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000445	CcSEcCtD
Cilostazol—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.71e-05	0.00216	CbGpPWpGaD
Cilostazol—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.7e-05	0.00215	CbGpPWpGaD
Cilostazol—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.68e-05	0.00214	CbGpPWpGaD
Cilostazol—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.62e-05	0.00213	CbGpPWpGaD
Cilostazol—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.59e-05	0.00212	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.53e-05	0.0021	CbGpPWpGaD
Cilostazol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.49e-05	0.00209	CbGpPWpGaD
Cilostazol—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.48e-05	0.00208	CbGpPWpGaD
Cilostazol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000425	CcSEcCtD
Cilostazol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000425	CcSEcCtD
Cilostazol—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000422	CcSEcCtD
Cilostazol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000419	CcSEcCtD
Cilostazol—PDE3A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.31e-05	0.00203	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.21e-05	0.002	CbGpPWpGaD
Cilostazol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000411	CcSEcCtD
Cilostazol—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.14e-05	0.00197	CbGpPWpGaD
Cilostazol—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000406	CcSEcCtD
Cilostazol—Rash—Prednisolone—chronic obstructive pulmonary disease	6.11e-05	0.000405	CcSEcCtD
Cilostazol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.11e-05	0.000405	CcSEcCtD
Cilostazol—Headache—Prednisolone—chronic obstructive pulmonary disease	6.07e-05	0.000402	CcSEcCtD
Cilostazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.84e-05	0.00188	CbGpPWpGaD
Cilostazol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000385	CcSEcCtD
Cilostazol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000382	CcSEcCtD
Cilostazol—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.76e-05	0.000382	CcSEcCtD
Cilostazol—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.73e-05	0.00184	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.71e-05	0.00184	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.65e-05	0.00181	CbGpPWpGaD
Cilostazol—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000371	CcSEcCtD
Cilostazol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000369	CcSEcCtD
Cilostazol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000369	CcSEcCtD
Cilostazol—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.57e-05	0.00179	CbGpPWpGaD
Cilostazol—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.5e-05	0.00177	CbGpPWpGaD
Cilostazol—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.49e-05	0.00176	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	5.4e-05	0.00173	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—MMP1—chronic obstructive pulmonary disease	5.36e-05	0.00172	CbGpPWpGaD
Cilostazol—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.27e-05	0.00169	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—PLAU—chronic obstructive pulmonary disease	5.26e-05	0.00169	CbGpPWpGaD
Cilostazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.24e-05	0.00168	CbGpPWpGaD
Cilostazol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.17e-05	0.00166	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.16e-05	0.00166	CbGpPWpGaD
Cilostazol—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.12e-05	0.00164	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.09e-05	0.00164	CbGpPWpGaD
Cilostazol—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000335	CcSEcCtD
Cilostazol—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.05e-05	0.00162	CbGpPWpGaD
Cilostazol—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.98e-05	0.00033	CcSEcCtD
Cilostazol—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.85e-05	0.00156	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.84e-05	0.00155	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—NOS2—chronic obstructive pulmonary disease	4.83e-05	0.00155	CbGpPWpGaD
Cilostazol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.000319	CcSEcCtD
Cilostazol—PDE3A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.78e-05	0.00154	CbGpPWpGaD
Cilostazol—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.78e-05	0.00154	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.78e-05	0.00154	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.75e-05	0.00153	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.68e-05	0.0015	CbGpPWpGaD
Cilostazol—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000309	CcSEcCtD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.64e-05	0.00149	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.51e-05	0.00145	CbGpPWpGaD
Cilostazol—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000297	CcSEcCtD
Cilostazol—Rash—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000294	CcSEcCtD
Cilostazol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000294	CcSEcCtD
Cilostazol—Headache—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000292	CcSEcCtD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.37e-05	0.0014	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.31e-05	0.00138	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.25e-05	0.00136	CbGpPWpGaD
Cilostazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.25e-05	0.00136	CbGpPWpGaD
Cilostazol—Nausea—Prednisone—chronic obstructive pulmonary disease	4.19e-05	0.000277	CcSEcCtD
Cilostazol—PDE3A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.1e-05	0.00132	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	4.07e-05	0.00131	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—ALB—chronic obstructive pulmonary disease	4.06e-05	0.0013	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.03e-05	0.00129	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.96e-05	0.00127	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.96e-05	0.00127	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.93e-05	0.00126	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.91e-05	0.00125	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	3.9e-05	0.00125	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.9e-05	0.00125	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.89e-05	0.00125	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.86e-05	0.00124	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.75e-05	0.0012	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.74e-05	0.0012	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.7e-05	0.00119	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.69e-05	0.00119	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.66e-05	0.00118	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.64e-05	0.00117	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.61e-05	0.00116	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.59e-05	0.00115	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.58e-05	0.00115	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.54e-05	0.00114	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.54e-05	0.00114	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.53e-05	0.00113	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	3.48e-05	0.00112	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.45e-05	0.00111	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.4e-05	0.00109	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.4e-05	0.00109	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.37e-05	0.00108	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.37e-05	0.00108	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.35e-05	0.00108	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.31e-05	0.00106	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.23e-05	0.00104	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.2e-05	0.00103	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.1e-05	0.000997	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.08e-05	0.00099	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.06e-05	0.000983	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.04e-05	0.000977	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.02e-05	0.000969	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.92e-05	0.000939	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.88e-05	0.000926	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.82e-05	0.000906	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.8e-05	0.000899	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.78e-05	0.000891	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.62e-05	0.000842	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.59e-05	0.000832	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.59e-05	0.00083	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.57e-05	0.000825	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.55e-05	0.00082	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.52e-05	0.000808	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.42e-05	0.000777	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.38e-05	0.000764	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.35e-05	0.000755	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.35e-05	0.000754	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.34e-05	0.000751	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.26e-05	0.000724	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.22e-05	0.000715	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.18e-05	0.0007	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.16e-05	0.000694	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.15e-05	0.000691	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TP53—chronic obstructive pulmonary disease	2.12e-05	0.000679	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2e-05	0.000642	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.98e-05	0.000637	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.98e-05	0.000635	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.97e-05	0.000631	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.94e-05	0.000625	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000611	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.89e-05	0.000608	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.000604	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.84e-05	0.000591	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.81e-05	0.000583	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.81e-05	0.000581	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.79e-05	0.000574	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.76e-05	0.000565	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.000551	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.68e-05	0.000538	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.66e-05	0.000534	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000507	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.56e-05	0.0005	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.52e-05	0.000487	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.45e-05	0.000464	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000463	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.41e-05	0.000452	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.38e-05	0.000443	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.37e-05	0.000441	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.36e-05	0.000436	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000423	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.32e-05	0.000423	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000417	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.24e-05	0.000398	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000389	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.2e-05	0.000386	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.17e-05	0.000376	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.17e-05	0.000375	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000369	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.14e-05	0.000367	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.00036	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.11e-05	0.000357	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.09e-05	0.000349	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000341	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.06e-05	0.000339	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.000337	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.79e-06	0.000314	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.77e-06	0.000314	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.66e-06	0.00031	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.58e-06	0.000308	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.52e-06	0.000306	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.49e-06	0.000305	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.39e-06	0.000302	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.83e-06	0.000284	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.81e-06	0.000283	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.75e-06	0.000281	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.71e-06	0.00028	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.54e-06	0.000274	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.3e-06	0.000266	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.28e-06	0.000266	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.18e-06	0.000263	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.12e-06	0.000261	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	7.8e-06	0.000251	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.63e-06	0.000245	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.47e-06	0.00024	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	7.46e-06	0.00024	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.36e-06	0.000237	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.26e-06	0.000233	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.17e-06	0.00023	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.77e-06	0.000218	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.77e-06	0.000217	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.68e-06	0.000215	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.56e-06	0.000211	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.41e-06	0.000206	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.39e-06	0.000205	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.31e-06	0.000203	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.22e-06	0.0002	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.9e-06	0.000189	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.76e-06	0.000185	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.74e-06	0.000184	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.66e-06	0.000182	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.64e-06	0.000181	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.39e-06	0.000173	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.31e-06	0.000171	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.27e-06	0.000169	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5e-06	0.000161	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.43e-06	0.000142	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.37e-06	0.00014	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.36e-06	0.00014	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.17e-06	0.000134	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.07e-06	0.000131	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.01e-06	0.000129	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.86e-06	0.000124	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.84e-06	0.000123	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.4e-06	0.000109	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.25e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.62e-06	8.42e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.51e-06	8.06e-05	CbGpPWpGaD
